Specify Sharps Containers as MMK Devices, Not Needle Codes

Direct Answer: Specify an FDA Class II sharps disposal container under 21 CFR 880.5570, product code MMK, with a verified 510(k) number—never under product code FMI (hypodermic single lumen needle) and never as a catalog color. OSHA 29 CFR 1910.1030(d)(4)(iii)(A)(1) requires contaminated-sharps containers that are closable, puncture resistant, leakproof on sides and bottom, and labeled or color-coded. During use they must be easily accessible, as close as feasible to the area where sharps are used or can reasonably be found, maintained upright, and not overfilled. A 510(k) substantial-equivalence determination is not official FDA approval under 21 CFR 807.97 and does not prove OSHA compliance. Declare ISO 23907-1:2019 (FDA Recognition Number 6-426) for single-use containers or ISO 23907-2:2019 (Recognition Number 6-437) for reusable containers. Reusable emptying and decontamination belong to the labeled reprocessor; OSHA 1910.1030(d)(4)(iii)(A)(4) prohibits employees from opening, emptying, or cleaning reusable containers in any manner that would expose them to percutaneous injury. Specify labeled total volume and labeled fill-line volume rather than copying FDA's "about three-fourths full" sentence onto every SKU. Treat ASTM F2132 as a withdrawn material test still listed as Rec# 6-215, not as a finished-container pass/fail, and do not treat ISO 23908 needle-shield standards as container tests.

A frequent error in hospital purchasing manifests when catalog descriptions or tender requisitions bundle sharps disposal boxes under general injection supply codes or misinterpret FDA device listings. Sharps containers marketed in the United States are Class II medical devices classified under 21 CFR 880.5570. Notably, 21 CFR 880.5570 formally identifies a "hypodermic single lumen needle" intended to inject or withdraw fluids. Within this regulatory classification, FDA regulates sharps disposal containers not as an isolated generic product category, but as classified accessories to hypodermic needles.

Device classification is delineated by three-letter FDA product codes. Sharps containers are assigned FDA product code MMK ("container, sharps"), reviewed by the Infection Control Devices branch (DHT4C) within CDRH. In contrast, hypodermic needles are assigned product code FMI ("needle, hypodermic, single lumen"), reviewed by the Drug Delivery and General Hospital Devices branch (DHT3C). A needle specification evaluates steel cannula metallurgy under ISO 9626, point geometry under ISO 7864, and hub color coding under ISO 6009—as detailed in the reference guide to hypodermic needle gauges and wall types. Specifying an FMI code or a needle gauge for a sharps disposal container is a classification error: the needle-gauge and hub-colour fields do not specify the container.

Buyers must also guard against an official clerical typo on FDA's public health-care facilities page. In its introductory overview, FDA writes that sharps disposal containers are classified under 21 CFR 880.5570 with product codes "MKK and FMI," whereas later paragraphs correctly cite "MMK" for Section 506J device supply notifications. The FDA product classification database and current 510(k) letters use product code MMK ("container, sharps") for the box and FMI for the needle. Specifying FMI, or copying the MKK typo into a tender, is a listing error.

Related consumable categories require distinct regulatory and functional specifications. Piston syringes must be specified under 21 CFR 880.5860 and ISO 7886-1 as outlined in sterile hypodermic syringe specifications, while dedicated insulin delivery requires specialized unit markings under ISO 8537 as detailed in insulin syringe specifications. Similarly, vascular access consumables require polyurethane or FEP catheter evidence under ISO 10555 as shown in IV cannula sizes and color codes. Receiving departments should verify Unique Device Identification barcodes using the protocols in UDI and GUDID capture for consumables, enforce environmental controls detailed in labeled storage and transport for medical consumables, and avoid conflating empty container procurement with the specialized transport packaging discussed in Category B specimen packaging under UN 3373.

Hospital supply-chain managers frequently assume that holding an FDA 510(k) clearance letter guarantees that a container satisfies workplace safety laws. This assumption is incorrect. The FDA premarket review assesses substantial equivalence to legally marketed predicate devices under the Federal Food, Drug, and Cosmetic Act. Meanwhile, the Occupational Safety and Health Administration (OSHA) enforces workplace engineering controls under federal labor law. Specifically, 29 CFR 1910.1030(d)(4)(iii)(A)(1) requires employers to discard contaminated sharps immediately or as soon as feasible in containers that fulfill four mandatory engineering parameters:

• Closable: A lid, flap, door, or other closing means, as OSHA's fact sheet restates. Dual-mode temporary pause versus permanent lock is a labeled closure field, not a numeric OSHA design table.

• Puncture-resistant: Rigid walls that resist puncture. OSHA does not publish a Newton pass/fail. Named finished-container penetration evidence belongs in the 510(k) or ISO 23907-1 report; ASTM F2132 is a material test only.

• Leakproof on sides and bottom: The OSHA construction field. Do not assume a two-piece body is leakproof because the catalog says rigid; ask for the labeled leak evidence and the 510(k) summary's OSHA 1910.1030 leakproof citation if present.

• Labeled or color-coded: Fluorescent orange or orange-red BIOHAZARD labels with contrasting lettering under 29 CFR 1910.1030(g)(1)(i), or a red container as the allowed color-code substitute. A yellow body in a cleared 510(k) still needed that label or an allowed substitute; red is not proof of clearance.

Workplace operational requirements extend beyond those four construction fields. Under OSHA 1910.1030(d)(4)(iii)(A)(2), containers must be easily accessible to personnel and located as close as feasible to the immediate area where sharps are used or can reasonably be found, maintained upright throughout use, and replaced routinely so they are not allowed to overfill. OSHA sets no numeric fill fraction. Before a container is moved from the area of use, it must be closed. If leakage is possible, OSHA requires a secondary container that is closable, constructed to contain all contents and prevent leakage during handling, storage, transport, or shipping, and labeled or color-coded under (g)(1)(i)—not a second puncture-resistance finding.

For reusable container systems, OSHA imposes an employee-protection rule: 29 CFR 1910.1030(d)(4)(iii)(A)(4) states that reusable containers shall not be opened, emptied, or cleaned manually or in any other manner which would expose employees to the risk of percutaneous injury. A hospital cannot buy a "reusable" box and instruct environmental services or sterile processing staff to tip it out, rinse it, or autoclave it on-site. Public reusable 510(k) summaries such as K132007 describe disinfection by the applicant prior to reuse and a container permanently marked for reuse. ISO 23907-2 recognition does not authorize employee emptying; emptying belongs to the labeled reprocessor named on that file, whether the work is done off-site or in a closed service loop.

Historically, FDA outlined the boundaries between FDA review and OSHA enforcement in its Guidance on the Content and Format of Premarket Notification [510(k)] Submissions for Sharps Containers, issued on 1 October 1993. That guidance formally stated that FDA does not enforce OSHA regulations per se, but evaluates whether container features support compliance with good infection-control practices under 29 CFR 1910.1030. Importantly, FDA officially withdrew this 1993 guidance on 14 January 2026. While the historical guidance checklist remains a practical engineering reference, buyers must cite active federal regulations (21 CFR 880.5570 and 29 CFR 1910.1030) rather than obsolete Agency guidance.

When evaluating technical tenders, procurement officers must demand declarations of conformity to the specific international standard governing the product's declared life-cycle model. The overarching standard, ISO 23907, was formally divided into two distinct parts in 2019, fundamentally changing specification requirements.

ISO 23907-1:2019 (First edition, published January 2019 and formally reconfirmed in 2024) governs single-use sharps containers. It specifies design verification and laboratory test methods for containers supplied complete or as user-assembled components intended to hold potentially hazardous medical sharps (including scalpel blades, trocars, hypodermic needles, and lancets). FDA maintains complete recognition of this standard under Recognition Number 6-426. Crucially, ISO 23907-1 explicitly excludes reusable containers from its scope, and it excludes outer secondary transport containers used for regulated medical waste transport under DOT regulations.

Buyers should reject supplier quality dossiers that cite only ISO 23907:2012 as the current single-use standard. ISO marks that edition withdrawn (stage 95.99); it was revised by ISO 23907-1:2019. Legacy 510(k) clearances issued around the transition (K180984, decision 3 January 2019) still listed Rec# 6-293 ISO 23907 First edition 2012-09-01 plus Rec# 6-215 ASTM F2132. Current single-use specifications should ask whether the file declares ISO 23907-1:2019 / Rec# 6-426, not only the withdrawn 2012 edition.

ISO 23907-2:2019 (First edition, published November 2019) governs reusable sharps containers. FDA recognizes it completely as Recognition Number 6-437. The public abstract includes design functionality for user safety, lifespan simulation, cleaning and decontamination, microbiological validation, quality monitoring, and performance testing. It is not applicable to single-use containers. K132007 (decision 27 December 2013) is a useful reusable-service pattern: 21 CFR 880.5570 Class II, product code MMK; 2-gallon and 4-gallon polypropylene-copolymer containers, red or yellow, counterbalanced lid, fluorescent orange or orange-red biohazard label; ASTM F2132-01:2008 puncture; DOT 49 CFR 173.197 and 178.603/606/608; OSHA 1910.1030; permanently marked for reuse and disinfected by the applicant prior to reuse. Do not treat that 2013 file as a declaration to ISO 23907-2:2019, which did not yet exist, and do not rank waste-contractor brands.

A persistent source of operational friction and tender rejection stems from confusing three distinct fill concepts: FDA's general descriptive language, manufacturer cleared fill volumes, and OSHA workplace rules. Sourcing specifications must clearly delineate these three metrics.

First, FDA's health-care-facilities page states that sharps disposal containers are "marked with a line to indicate when the container is about three-fourths (3/4) full" and tells users to close and seal following the manufacturer's instructions when about three-fourths full. FDA's separate consumer page uses the same three-quarters language for home users. That 3/4 sentence is FDA's typical marked-line explanation, not a regulation and not every 510(k)'s fill fraction. Do not copy it onto a purchase order if the label states a different usable volume.

Second, cleared manufacturer specifications set labeled fill-line volumes that can differ from 75%. In public 510(k) summary data for K222905 (decision 1 June 2023), the labeled fill-line capacity is 80% of total nominal volume for those models. Quote those figures only as that file's public table, not as a universal ISO or OSHA fraction:

• 1.0 Quart Nominal Model (MA1112): Total volume 1.0 quart; labeled fill-line capacity 0.80 quart (80.0%).

• 5.4 Quart Wall-Mount Model (MA1212/1213): Total volume 5.4 quarts; labeled fill-line capacity 4.32 quarts (80.0%).

• 7.0 Liter Mobile Unit (MA1324): Total volume 7.0 liters; labeled fill-line capacity 5.60 liters (80.0%).

Writing a purchasing specification that requires a marked fill line at exactly 75%—or at exactly 80%—will reject properly cleared devices whose labels use a different usable volume. Require each SKU to display a permanent fill mark and to state both total volume and labeled usable fill volume as listed in the 510(k).

Third, OSHA enforces a workplace practice rule under 29 CFR 1910.1030(d)(4)(iii)(A)(2)(iii): containers must be "replaced routinely and not be allowed to overfill." OSHA specifies no numeric percentage. NIOSH Publication 97-111 (Selecting, Evaluating, and Using Sharps Disposal Containers, January 1998) remains a public selection framework of functionality, accessibility, visibility, and accommodation based on a site-specific hazard analysis. It does not set a fill-line fraction, it does not replace OSHA 1910.1030 or a 510(k), and its 1998 needlestick incidence figures must not be restated as current rates. Visibility can be a labeled window, a translucent component (K180984 describes one translucent component to check the fill line), or another labeled indicator—do not fail an opaque SKU solely for lacking a sight stripe.

Puncture resistance is the paramount safety attribute of any sharps receptacle. However, significant confusion exists in distributor catalogs regarding what constitutes valid test evidence. Value-analysis committees frequently encounter two divergent standards: ISO 23907-1 and ASTM F2132.

ASTM F2132-01 (Reapproved 2008)e1 is currently listed in FDA's recognized consensus standards database as Recognition Number 6-215 for product code MMK. However, ASTM International officially withdrew F2132 in 2017 without immediate replacement. More critically, the explicit public scope of ASTM F2132 states that the standard evaluates only the puncture resistance of flat specimen materials under controlled laboratory conditions (23 ± 2 °C). The scope specifically warns that ASTM F2132 "does not evaluate the construction of, or provide pass/fail criteria for, a sharps container." Citing compliance with ASTM F2132 proves that a molded polymer plaque resists a sharp tip under laboratory conditions; it provides zero evidence regarding whether an assembled container seam, hinge, or lid resists penetration.

In contrast, ISO 23907-1:2019 (FDA Rec# 6-426) is the current single-use container standard with finished-article tests. Public K222905 text names ISO 23907-1:2019 tests for container stability, handle strength, resistance to penetration, resistance to damage and leakage after dropping, resistance to spillage by toppling, and label integrity including a fill line. That summary's stated penetration acceptance is a minimum of 16 N and an average of 18 N or greater. Quote those Newton figures only as K222905's public criterion, not as a universal ISO table reprint and not as an OSHA numeric limit. Other MMK files may declare different tests (K180984 and K132007 cite ASTM F2132 material puncture without those Newton values).

Buyers must also avoid confusing container standards with needle safety features. The MMK product classification database entry lists ISO 23908:2011 (FDA Rec# 6-273) and ISO 23908:2024 (FDA Rec# 6-507). These standards evaluate sharps-injury protection features built into needles, IV catheters, and lancets (such as active hinged shields or passive spring retractors). ISO 23908 does not test disposal containers. FDA has announced that declarations of conformity to Rec# 6-273 will be accepted only until 4 July 2027, after which Rec# 6-507 will govern needle protection. Tenders must never accept an ISO 23908 certificate as evidence for a sharps disposal container.

Turn the identity map into purchase-order rows: lid geometry, aperture, mounting, and labelled colour. Specify those fields as they appear on the 510(k) and the label. Do not invent a universal aperture catalog or a chemo-colour chart.

Aperture and drop style: FDA's facilities page describes a tight-fitting, puncture-resistant lid whose opening admits a sharp but is not large enough for a hand. Public 510(k) lid fields are the specification. Named examples in K222905 are hinged, counterbalanced, and star-hinged closures; K132007 uses a gravity-activated counterbalanced lid. Record the labeled geometry rather than a marketplace synonym.

• Hinged closure: K222905's 1-quart MA1112 public lid field is a hinged closure with a holder; specify the labeled hinge and lock, not a catalog synonym.

• Counterbalanced door: K222905 MA1212/MA1213 list counterbalanced doors with locking wall brackets. K132007 describes a gravity-activated counterbalanced lid as a reach-in barrier. Name the labeled lid, not a brand ranking.

• Star-hinged door: K222905 MA1324 lists a star-hinged door on a free-standing 7-liter model. Do not rewrite that labeled geometry as an elastomeric "star baffle" unless the label uses those words.

• Needle unwinder or one-handed disconnection, if present: If the aperture is labeled with an unwinder or disconnection notch, record that labeled feature. OSHA 1910.1030 restricts bending, recapping, and removing contaminated needles except under stated conditions; it is not a current FDA container-design mandate. The withdrawn October 1993 FDA 510(k) guidance listed one-handed unwinders and no bend/break/shear features as a historical checklist that later 510(k)s still echo (K180984 states no feature to bend, break, or shear). Do not write recapping technique.

Mounting hardware and unsupervised-access limits: Specify the labeled mounting accessory—free-standing, locking wall bracket, holder, or cart—rather than an invented working height. K222905 states the containers are for qualified personnel and are not for unsupervised patient access. OSHA's contaminated-sharps fact sheet notes that, in some cases, containers may be placed on carts to prevent patients such as psychiatric patients or children from accessing the sharps. That is a workplace-location option under OSHA's "as close as feasible" rule, not a specification to install a particular locked cabinet on every pediatric or memory-care unit, and not a clinical placement SOP.

Coloration is not a federal waste-stream chart: Under OSHA 1910.1030(g)(1)(i), fluorescent orange or orange-red BIOHAZARD labels are required, and red bags or red containers may be substituted for labels. That color-code option is not a mandate that every container be red, and it is not a chemotherapy or pharmaceutical waste-stream colour table. Yellow bodies appear in K222905 (MA1324 yellow base) and K132007 (red or yellow); those SKUs still needed the OSHA label or an allowed substitute. Record this manufacturer's labeled colour plus the OSHA label or allowed red colour-code. Do not invent a federal chemo-colour table.

flowchart TD
    A["Requisition: sharps container"] --> B{"Class II accessory?\n21 CFR 880.5570"}
    B -- "No" --> C["Reject: unregulated carton or FMI needle code"]
    B -- "Yes" --> D{"Product code MMK?\nVerified 510(k) number?"}
    D -- "No" --> E["Reject: facility-page typo MKK or missing 510(k)"]
    D -- "Yes" --> F{"Labeled disposal model"}
    F -- "Single-use" --> G["ISO 23907-1:2019 Rec# 6-426\nReject withdrawn ISO 23907:2012"]
    F -- "Reusable" --> H["ISO 23907-2:2019 Rec# 6-437\nEmptying only by labeled reprocessor"]
    G --> I{"OSHA 1910.1030 fields"}
    H --> I
    I --> J["Closable, puncture resistant, leakproof sides and bottom\nLabeled or color-coded, used upright, not overfilled\nLabeled total volume and labeled fill-line volume\nNamed puncture evidence: ISO 23907-1 article test and/or ASTM F2132 material test"]
    J --> K["Issue purchase order after value-analysis review"]

Hospital receiving docks, value-analysis committees, and safety auditors should utilize the following 12-point worksheet to verify compliance before accepting consumable shipments or awarding supply contracts.